XML 35 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Discontinued Operations
 3 Months Ended
Mar. 31, 2026
Discontinued Operations [Abstract]  
DISCONTINUED OPERATIONS

NOTE 17 – DISCONTINUED OPERATIONS

 

During the prior period presented, the Company executed actions to abandon its pharmaceutical research operations and the Gaming Technology Platform which met the criteria to be classified as discontinued operations in accordance with ASC 205-20, Presentation of Financial Statements – Discontinued Operations.

  

Financial Information of Discontinued Operations

 

Summarized balance sheet information of discontinued operations is below (in thousands):

 

   March 31,
2026		   December 31,
2025		 
         
Cash and cash equivalents  $195   $12 
Prepaid expenses and other current assets   61    10 
Current assets of discontinued operations   256    22 
Intangible assets1   
-
    
-
 
Total assets of discontinued operations  $256   $22 
           
Accounts payable  $26   $8 
Accounts payable – related parties   162    1,185 
Accrued expenses   35    32 
Loan payable –current portion   
-
    7 
Current liabilities of discontinued operations   223    1,232 
Loan payable –noncurrent portion   
-
    
-
 
Total liabilities of discontinued operations  $223   $1,232 

 

(1)Consists of Gaming Technology Platform intangible assets pursuant to the September 2024 Asset Purchase Agreement with Elray, which were impaired in full during the year ended December 31, 2025.

  

The statements of operations of discontinued operations are summarized below (in thousands):

 

   Three Months Ended
March 31,		 
   2026   2025 
Research and development  $
-
   $(241)
Research and development - related parties   
-
    (135)
General and administrative   (320)   (29)
Loss from operations   (320)   (405)
Other income   22    
-
 
Interest expense   
-
    (3)
Gain on settlement of liabilities   1,568    
-
 
Net income (loss) from discontinued operations  $1,270   $(408)